DKK ten million to boost new treatment for infertile women
Professor Karin Lykke-Hartmann from Aarhus University is working to develop an alternative to the traditional hormone treatment of female infertility. After years of research and a large grant from the BioInnovation Institute, she is now ready to kick start a new treatment option.
As professor of reproductive medicine, Karin Lykke-Hartmann identifies and maps the molecular mechanisms that help regulate the maturation of eggs in women's ovaries. She has discovered new molecular signalling pathways in the ovaries and using the right compound these will be able to help the maturation of the woman's eggs. The objective is to develop a treatment for infertile women who do not benefit from, or cannot tolerate, the standard hormonal treatment that is available today. If the project is successful, millions of women all over the world will be helped with better fertility treatment.
Based on the research carried out at the university, Karin Lykke-Hartmann and her research team have founded the spin-out company iNotify, which will develop the new fertility treatment free from hormones. The BioInnovation Institute has given the company a grant of DKK ten million to help it on its way. The next step for the innovative researchers is to test the safety profile of the treatment and the compound on a larger scale, so that it can be approved by the Danish Medicines Agency.
Contact
Professor Karin Lykke-Hartmann
Aarhus University, Department of Biomedicine
Mobile: (+45) 2939 0558
Email: kly@biomed.au.dk